Advocacy Actions
President Wuttke Met with Ambassador-designate to the European Union (EU), HE Mr Fu Cong
On 2nd November, President Jörg Wuttke was received by HE Mr FU Cong, Ambassador-designate to the EU, in Beijing. An open and frank exchange on current issues took place, with regard to bilateral relations, recent trade and investments between the two economies, COVID-19 containment and the development of European businesses in China.
Read moreEnergy Working Group Speaks at the 2nd Carbon Neutrality Conference in Tianjin
The European Chamber Tianjin Chapter organised its 2nd Carbon Neutrality Conference: The Role of European Business in China's Race to 2060 along with Green Partnership of Industrial Parks at Shangri-La Hotel Tianjin on Wednesday, 2nd November 2022. This event is also in memory of Guido Giacconi, former Vice President of the European Chamber, and a former passionate leader of the Chamber’s Energy Working Group, who visited Tianjin several times and supported this conference as the keynote speaker last year. Mickael Naouri, Vice Chair of the European Chamber Energy Working Group made a presentation on the work of the energy working group and moderated the panel discussion.
Read moreSubmission of Comments on the People's Republic of China Customs Administrative Punishment Discretionary Benchmarks (I) (Draft for Comments)
Submitted Comments on the People's Republic of China Customs Administrative Punishment Discretionary Benchmarks (I) (Draft for Comments)
Read moreEuropean Chamber representatives meet with the Cabinet of Executive Vice-President Margrethe Vestager
On 28th October, a group of European Chamber representatives led by President Joerg Wuttke met with members of the Cabinet of Executive Vice-President Margrethe Vestager.
Read moreComment and Recommendation to Centre for Medical Device Evaluation on a survey regarding discrepancy between name of medical device approved by NMPA and in the medical insurance catalogue
Collecting comment to Centre for Medical Device Evaluation on a survey regarding discrepancy between name of medical device approved by NMPA and in the medical insurance catalogue
Read morePolicy interpretation regarding new customs inspection acceptance scheme
On the 28th of October, the Fashion and Leather working group had a consultation with GACC for clarification of issues about the customs' product inspection acceptance scheme.
The 4Q Meeting with NMPA on regulation concerns in cosmetics industry
On 27th October, National Medical Products Administration (NMPA) organised the forth quarter meeting with local MPA and chambers and associations on the latest concerns in the cosmetics industry.
Read moreMeeting on Decarbonization for Automotive
Held the first meeting of the series themed on Decarbonization for Automotive Industry on 26 October.
Read moreAdvocacy Letter to the NHC, CFSA and SAMR on Postponing the Announcement of the New Testing Method for Vitamin A
On October 24th, European Chamber Paediatric Nutrition Sub-working Group and Food for Special Medical Purpose Advisory Committee sent an advocacy letter to the NHC, CFSA and SAMR, suggesting postponing the announcement of the new testing method for Vitamin A given the wide impact on the industry.
Read moreAdvocacy Letter to the NHC, CFSA and SAMR on Postponing the Announcement of the New Testing Method for Vitamin A
On October 24th, European Chamber Paediatric Nutrition Sub-working Group and Food for Special Medical Purpose Advisory Committee sent an advocacy letter to the NHC, CFSA and SAMR, suggesting postponing the announcement of the new testing method for Vitamin A.
Read more